Accel Research Sites featured in CNBC article about Pfizer vaccine effectiveness in children - Accel Research Sites

Create a Profile

I accept digital forms of communication(Required)
Hidden
Hidden
This field is for validation purposes and should be left unchanged.
Create a Profile
I accept digital forms of communication(Required)
Hidden
Hidden
This field is for validation purposes and should be left unchanged.

Get In Touch Mobile

I accept digital forms of communication(Required)
This field is for validation purposes and should be left unchanged.

FIND A TRIAL NEAR YOU

No location found for this Zip Code

-- or --

No location found for this Location

FIND A TRIAL NEAR YOU

No location found for this Zip Code

-- or --

No location found for this Location
Back
Date Published: 10/27/2021

Accel Research Sites featured in CNBC article about Pfizer vaccine effectiveness in children

The CDC has reported positive numbers regarding Pfizer’s pediatric COVID-19 vaccine for children ages 12 to 18 years old.

The CDC found the vaccine is over 93% effective against hospitalization for that age group.

Dr. Salma Elfaki was a part of several pediatric COVID-19 vaccine clinical trials and was featured seeing a patient in a photo in the article.

See it here.

Back

Ready to be part of healthcare history? Find the right clinical trial for you.

Get In Touch

I accept digital forms of communication(Required)
This field is for validation purposes and should be left unchanged.
Accessibility Adjustment

Color Adjustment

Orientation Adjustment

Font Size

 

Line height